Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 56 of 173 for:    pertuzumab

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in Her-positive, Her2-positive Metastatic Breast

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03304080
Recruitment Status : Recruiting
First Posted : October 6, 2017
Last Update Posted : February 4, 2019
Sponsor:
Collaborators:
Herbert Irving Comprehensive Cancer Center
Weill Medical College of Cornell University
NYU Langone Health
Information provided by (Responsible Party):
Amy Tiersten, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2019
Estimated Study Completion Date : November 1, 2020